Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jan 2019. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3731619018 | Efalizumab only product | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 3731620012 | Product containing only efalizumab (medicinal product) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 2857871000001111 | Efalizumab (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom Edition module |
| 2857881000001113 | Efalizumab | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom Edition module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Efalizumab | Has active ingredient | Efalizumab | true | Inferred relationship | Existential restriction modifier | 1 | |
| Efalizumab | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
| Efalizumab | Is a | Product containing efalizumab | true | Inferred relationship | Existential restriction modifier | ||
| Efalizumab | Is a | Virtual therapeutic moiety | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Efalizumab 125mg powder and solvent for solution for injection vials | Is a | True | Efalizumab | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR